Correlation Between Caribou Biosciences and Heron Therapeuti
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Heron Therapeuti at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Heron Therapeuti into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Heron Therapeuti, you can compare the effects of market volatilities on Caribou Biosciences and Heron Therapeuti and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Heron Therapeuti. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Heron Therapeuti.
Diversification Opportunities for Caribou Biosciences and Heron Therapeuti
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Caribou and Heron is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Heron Therapeuti in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heron Therapeuti and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Heron Therapeuti. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heron Therapeuti has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Heron Therapeuti go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Heron Therapeuti
Given the investment horizon of 90 days Caribou Biosciences is expected to generate 0.81 times more return on investment than Heron Therapeuti. However, Caribou Biosciences is 1.24 times less risky than Heron Therapeuti. It trades about 0.08 of its potential returns per unit of risk. Heron Therapeuti is currently generating about -0.3 per unit of risk. If you would invest 188.00 in Caribou Biosciences on August 29, 2024 and sell it today you would earn a total of 14.00 from holding Caribou Biosciences or generate 7.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Caribou Biosciences vs. Heron Therapeuti
Performance |
| Timeline |
| Caribou Biosciences |
| Heron Therapeuti |
Caribou Biosciences and Heron Therapeuti Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Caribou Biosciences and Heron Therapeuti
The main advantage of trading using opposite Caribou Biosciences and Heron Therapeuti positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Heron Therapeuti can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heron Therapeuti will offset losses from the drop in Heron Therapeuti's long position.| Caribou Biosciences vs. Eliem Therapeutics | Caribou Biosciences vs. Scpharmaceuticals | Caribou Biosciences vs. Milestone Pharmaceuticals | Caribou Biosciences vs. Seres Therapeutics |
| Heron Therapeuti vs. Mereo BioPharma Group | Heron Therapeuti vs. Terns Pharmaceuticals | Heron Therapeuti vs. PDS Biotechnology Corp | Heron Therapeuti vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |